Xtant Medical Holdings Inc (XTNT)
0.527
+0.06
(+12.58%)
USD |
NYAM |
Jan 03, 16:00
0.499
-0.03
(-5.31%)
After-Hours: 20:00
Xtant Medical Holdings Research and Development Expense (Annual): 1.336M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
Plus Therapeutics Inc | 9.69M |
Perspective Therapeutics Inc | 21.31M |
Retractable Technologies Inc | 0.5812M |
InfuSystems Holdings Inc | -- |
Catheter Precision Inc | 0.475M |